NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/28/2023
Back to search
Official data from USPTO
FUSION BIOVENTURE FOSUN PHARMA US INNOVATION HUB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
10
Latest update
03/28/2023
Classification
Registered
Trademark type
Combined
Nice classes
36, 42
Filing date
02/21/2022
Registration date
03/28/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/28/2023
Last transaction
03/28/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2020-09-00
First use in commerce
2020-09-00
Drawing code
3
Owner type
03
Owner location
Lexington, MA
Examiner
KING, LINDA
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the blue word FUSION in capitalized text, with the orange word BIOVENTURE to its right, oriented vertically, all above the blue text FOSUN PHARMA US INNOVATION HUB, which is next to a small blue triangle. The O in FUSION is displayed around a stylized flame comprising an orange semi-circular shape at the bottom, a set of three gradient orange and yellow vertical lines in the middle, and a grid of fifteen orange dots at the top. The areas shown in white are for background only and are not claimed as part of the mark.
Holders and representatives
Holders
Fosun Pharma USA Inc.
Representatives
PERRY GATTEGNO LITWIN KACH LLP
Technical classification
Nice Classes
Class 36Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Providing venture capitaldevelopment capitalprivate equity and investment funding; Venture capital servicesproviding financing to emerging and start-up companies
Class 42
Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Researchdevelopmentengineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Consulting services in the field of pharmacogenetics; Pharmaceutical research and development; Scientific research and development; Vaccine research and development
Publications
History of USPTO decisions and trademark events.
10 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/28/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/10/2023
PUBO
PUBLISHED FOR OPPOSITION
01/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/21/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/06/2022
DOCK
ASSIGNED TO EXAMINER
12/05/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/25/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/24/2022
NWAP
NEW APPLICATION ENTERED
02/24/2022
Continuous trademark protection
Get notified about every new filing that threatens FUSION BIOVENTURE FOSUN PHARMA US INNOVATION HUB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.